RAVINDRA MEHTA: Open Payments
NPI 1063599835 · BROWNSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,965 in 133 payments from 13 companies in 2025. Trend: 2023 $2,277 · 2024 $2,284 · 2025 $2,965
Food & beverage: $2,965
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $589 |
| Neurocrine BioSciences, Inc. | 20 | $496 |
| Otsuka America Pharmaceutical, Inc. | 27 | $370 |
| E.R. Squibb & Sons, L.L.C. | 15 | $331 |
| Janssen Pharmaceuticals, Inc | 16 | $273 |
| Alkermes, Inc. | 11 | $256 |
| Axsome Therapeutics, Inc. | 6 | $234 |
| Teva Pharmaceuticals USA, Inc. | 4 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
Products named: INGREZZA, FANAPT, COBENFY, REXULTI, INVEGA SUSTENNA, ARISTADA, Auvelity, HETLIOZ.
Industry payments across PA — which companies pay providers there.
